Download PDF
Semin Neurol 2006; 26(4): 413-421
DOI: 10.1055/s-2006-948322
Copyright © 2006 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Biomarkers and Neuroimaging of Brain Injury after Cardiac Arrest

Prem Kandiah1 , Santiago Ortega1 , Michel T. Torbey1 , 2
  • 1Department of Neurology, Medical College of Wisconsin, Milwaukee, Wisconsin
  • 2Department of Neurosurgery, Medical College of Wisconsin, Milwaukee, Wisconsin
Further Information

Publication History

Publication Date:
10 August 2006 (online)

    Permissions and Reprints

ABSTRACT

Unfortunately, it remains a difficult task to predict with certainty which patients will have a poor neurological outcome following cardiac arrest. Finding a quantitative prognostic model of outcome has become the objective of many intensivists to assist grieving families in making early difficult decisions regarding withdrawal of life support. An ideal prognostic test should be readily available, easily reproducible, and associated with a high degree of specificity for poor outcome. The goal is not to define which patients may recover, but rather which patients have no likelihood of meaningful neurological recovery at all to justify early withdrawal of support. The literature and the role of biochemical markers in the blood and in the cerebrospinal fluid will be evaluated as prognosticators following cardiac arrest. Radiological indicators of anoxic cerebral damage are reviewed. Each serum or radiological marker has its pros and cons. To accurately prognosticate following cardiac arrest, a multimodal scale or algorithm that incorporates serum markers, radiological markers, and the neurological exam is clearly needed. As these techniques are being evaluated more closely and as imaging modalities increase in sensitivity and portability, physicians will continue to assist families by providing some guidance as to which patients have no chance of meaningful recovery.

KEYWORDS

Neuron-specific enolase - S-100 - cardiac arrest - radiological markers - serum markers - prognostication

REFERENCES

  • 1 Kouwenhoven W B, Jude J R, Knickerbocker G G. Landmark article July 9, 1960: closed-chest cardiac massage. By W.B. Kouwenhoven, James R. Jude, and G. Guy Knickerbocker.  JAMA. 1984;  251 3133-3136
    CrossrefPubMedGoogle Scholar
  • 2 Cummins R O, Eisenberg M S, Hallstrom A P, Litwin P E. Survival of out-of-hospital cardiac arrest with early initiation of cardiopulmonary resuscitation.  Am J Emerg Med. 1985;  3 114-119
    CrossrefPubMedGoogle Scholar
  • 3 Brain Resuscitation Clinical Trial I Study Group . Randomized clinical study of thiopental loading in comatose survivors of cardiac arrest.  N Engl J Med. 1986;  314 397-403
    PubMedGoogle Scholar
  • 4 Levy D E, Bates D, Caronna J J et al.. Prognosis in nontraumatic coma.  Ann Intern Med. 1981;  94 293-301
    CrossrefPubMedGoogle Scholar
  • 5 Levy D E, Caronna J J, Singer B H, Lapinski R H, Frydman H, Plum F. Predicting outcome from hypoxic-ischemic coma.  JAMA. 1985;  253 1420-1426
    CrossrefPubMedGoogle Scholar
  • 6 Longstreth Jr W T, Diehr P, Inui T S. Prediction of awakening after out-of-hospital cardiac arrest.  N Engl J Med. 1983;  308 1378-1382
    CrossrefPubMedGoogle Scholar
  • 7 Jennett B, Bond M. Assessment of outcome after severe brain damage.  Lancet. 1975;  1 480-484
    Google Scholar
  • 8 Hamel M B, Goldman L, Teno J et al.. Identification of comatose patients at high risk for death or severe disability. SUPPORT Investigators: Understand Prognoses and Preferences for Outcomes and Risks of Treatments.  JAMA. 1995;  273 1842-1848
    CrossrefPubMedGoogle Scholar
  • 9 Gueugniaud P Y, Garcia-Darennes F, Gaussorgues P, Bancalari G, Petit P, Robert D. Prognostic significance of early intracranial and cerebral perfusion pressures in post-cardiac arrest anoxic coma.  Intensive Care Med. 1991;  17 392-398
    CrossrefPubMedGoogle Scholar
  • 10 Gustafson I, Edgren E, Hulting J. Brain-oriented intensive care after resuscitation from cardiac arrest [see comment].  Resuscitation. 1992;  24 245-261
    CrossrefPubMedGoogle Scholar
  • 11 Anastasiades K D, Mullins R E, Conn R B. Neuron-specific enolase: assessment by ELISA in patients with small cell carcinoma of the lung.  Am J Clin Pathol. 1987;  87 245-249
    PubMedGoogle Scholar
  • 12 Hay E, Royds J A, Davies-Jones G A, Lewtas N A, Timperley W R, Taylor C B. Cerebrospinal fluid enolase in stroke.  J Neurol Neurosurg Psychiatry. 1984;  47 724-729
    PubMedGoogle Scholar
  • 13 Persson L, Hardemark H G, Gustafsson J et al.. S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system.  Stroke. 1987;  18 911-918
    PubMedGoogle Scholar
  • 14 Studahl M, Rosengren L, Gunther G, Hagberg L. Difference in pathogenesis between herpes simplex virus type 1 encephalitis and tick-borne encephalitis demonstrated by means of cerebrospinal fluid markers of glial and neuronal destruction.  J Neurol. 2000;  247 636-642
    PubMedGoogle Scholar
  • 15 Royds J A, Timperley W R, Taylor C B. Levels of enolase and other enzymes in the cerebrospinal fluid as indices of pathological change.  J Neurol Neurosurg Psychiatry. 1981;  44 1129-1135
    PubMedGoogle Scholar
  • 16 Correale J, Rabinowicz A L, Heck C N, Smith T D, Loskota W J, DeGiorgio C M. Status epilepticus increases CSF levels of neuron-specific enolase and alters the blood-brain barrier.  Neurology. 1998;  50 1388-1391
    PubMedGoogle Scholar
  • 17 Roine R O, Somer H, Kaste M, Viinikka L, Karonen S L. Neurological outcome after out-of-hospital cardiac arrest: prediction by cerebrospinal fluid enzyme analysis.  Arch Neurol. 1989;  46 753-756
    CrossrefPubMedGoogle Scholar
  • 18 Schaarschmidt H, Prange H W, Reiber H. Neuron-specific enolase concentrations in blood as a prognostic parameter in cerebrovascular diseases.  Stroke. 1994;  25 558-565
    CrossrefPubMedGoogle Scholar
  • 19 Dauberschmidt R, Zinsmeyer J, Mrochen H, Meyer M. Changes of neuron-specific enolase concentration in plasma after cardiac arrest and resuscitation.  Mol Chem Neuropathol. 1991;  14 237-245
    PubMedGoogle Scholar
  • 20 Fogel W, Krieger D, Veith M et al.. Serum neuron-specific enolase as early predictor of outcome after cardiac arrest.  Crit Care Med. 1997;  25 1133-1138
    CrossrefPubMedGoogle Scholar
  • 21 Martens P. Serum neuron-specific enolase as a prognostic marker for irreversible brain damage in comatose cardiac arrest survivors.  Acad Emerg Med. 1996;  3 126-131
    PubMedGoogle Scholar
  • 22 Rosen H, Rosengren L, Herlitz J, Blomstrand C. Increased serum levels of the S-100 protein are associated with hypoxic brain damage after cardiac arrest.  Stroke. 1998;  29 473-477
    PubMedGoogle Scholar
  • 23 Schoerkhuber W, Kittler H, Sterz F et al.. Time course of serum neuron-specific enolase: a predictor of neurological outcome in patients resuscitated from cardiac arrest.  Stroke. 1999;  30 1598-1603
    PubMedGoogle Scholar
  • 24 Meynaar I A, Straaten H M, van der Wetering J et al.. Serum neuron-specific enolase predicts outcome in post-anoxic coma: a prospective cohort study.  Intensive Care Med. 2003;  29 189-195
    PubMedGoogle Scholar
  • 25 Tiainen M, Roine R O, Pettila V, Takkunen O. Serum neuron-specific enolase and S-100B protein in cardiac arrest patients treated with hypothermia.  Stroke. 2003;  34 2881-2886
    CrossrefPubMedGoogle Scholar
  • 26 Martens P, Raabe A, Johnsson P. Serum S-100 and neuron-specific enolase for prediction of regaining consciousness after global cerebral ischemia.  Stroke. 1998;  29 2363-2366
    CrossrefPubMedGoogle Scholar
  • 27 Rosen H, Sunnerhagen K S, Herlitz J, Blomstrand C, Rosengren L. Serum levels of the brain-derived proteins S-100 and NSE predict long-term outcome after cardiac arrest.  Resuscitation. 2001;  49 183-191
    CrossrefPubMedGoogle Scholar
  • 28 Bottiger B W, Mobes S, Glatzer R et al.. Astroglial protein S-100 is an early and sensitive marker of hypoxic brain damage and outcome after cardiac arrest in humans.  Circulation. 2001;  103 2694-2698
    PubMedGoogle Scholar
  • 29 Heizmann C W. Ca2 + -binding S100 proteins in the central nervous system.  Neurochem Res. 1999;  24 1097-1100
    CrossrefPubMedGoogle Scholar
  • 30 Donato R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles.  Int J Biochem Cell Biol. 2001;  33 637-668
    CrossrefPubMedGoogle Scholar
  • 31 Li Y, Barger S W, Liu L, Mrak R E, Griffin W S. S100beta induction of the proinflammatory cytokine interleukin-6 in neurons.  J Neurochem. 2000;  74 143-150
    CrossrefPubMedGoogle Scholar
  • 32 Hachimi-Idrissi S, Van der Auwera M, Schiettecatte J, Ebinger G, Michotte Y, Huyghens L. S-100 protein as early predictor of regaining consciousness after out of hospital cardiac arrest.  Resuscitation. 2002;  53 251-257
    CrossrefPubMedGoogle Scholar
  • 33 Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest.  N Engl J Med. 2002;  346 549-556
    CrossrefPubMedGoogle Scholar
  • 34 Bernard S A, Gray T W, Buist M D et al.. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia.  N Engl J Med. 2002;  346 557-563
    CrossrefPubMedGoogle Scholar
  • 35 Calle P A, Buylaert W A, Vanhaute O A. Glycemia in the post-resuscitation period. The Cerebral Resuscitation Study Group.  Resuscitation. 1989;  17(suppl) S181-S188 , discussion S199-S206
    CrossrefPubMedGoogle Scholar
  • 36 Fang J F, Chen R J, Lin B C et al.. Prognosis in presumptive hypoxic-ischemic coma in nonneurologic trauma.  J Trauma. 1999;  47 1122-1125
    PubMedGoogle Scholar
  • 37 Longstreth Jr W T, Diehr P, Cobb L A, Hanson R W, Blair A D. Neurologic outcome and blood glucose levels during out-of-hospital cardiopulmonary resuscitation.  Neurology. 1986;  36 1186-1191
    PubMedGoogle Scholar
  • 38 Longstreth Jr W T, Inui T S, Cobb L A, Copass M K. Neurologic recovery after out-of-hospital cardiac arrest.  Ann Intern Med. 1983;  98 588-592
    CrossrefPubMedGoogle Scholar
  • 39 Mullner M, Sterz F, Domanovits H, Behringer W, Binder M, Laggner A N. The association between blood lactate concentration on admission, duration of cardiac arrest, and functional neurological recovery in patients resuscitated from ventricular fibrillation.  Intensive Care Med. 1997;  23 1138-1143
    CrossrefPubMedGoogle Scholar
  • 40 Edgren E, Hedstrand U, Nordin M, Rydin E, Ronquist G. Prediction of outcome after cardiac arrest.  Crit Care Med. 1987;  15 820-825
    CrossrefPubMedGoogle Scholar
  • 41 Chandler W L, Clayson K J, Longstreth Jr W T, Fine J S. Creatine kinase isoenzymes in human cerebrospinal fluid and brain.  Clin Chem. 1984;  30 1804-1806
    PubMedGoogle Scholar
  • 42 Longstreth Jr W T, Clayson K J, Chandler W L, Sumi S M. Cerebrospinal fluid creatine kinase activity and neurologic recovery after cardiac arrest.  Neurology. 1984;  34 834-837
    PubMedGoogle Scholar
  • 43 Goe M R, Massey T H. Assessment of neurologic damage: creatine kinase-BB assay after cardiac arrest.  Heart Lung. 1988;  17 247-253
    PubMedGoogle Scholar
  • 44 Osborn A. Stroke. In: Osborn A, Maack J Diagnostic Neuroradiology. St. Louis; Mosby 1994: 330-398
    Google Scholar
  • 45 Castillo M. Imaging of cerebral infarction.  Curr Probl Diagn Radiol. 1998;  27 105-131
    PubMedGoogle Scholar
  • 46 Singhal A B, Topcuoglu M A, Koroshetz W J. Diffusion MRI in three types of anoxic encephalopathy.  J Neurol Sci. 2002;  196 37-40
    CrossrefPubMedGoogle Scholar
  • 47 Roine R O, Raininko R, Erkinjuntti T, Ylikoski A, Kaste M. Magnetic resonance imaging findings associated with cardiac arrest.  Stroke. 1993;  24 1005-1014
    PubMedGoogle Scholar
  • 48 Hossmann K A, Schuier F J. Experimental brain infarcts in cats: I. Pathophysiological observations.  Stroke. 1980;  11 583-592
    PubMedGoogle Scholar
  • 49 Iida K, Satoh H, Arita K, Nakahara T, Kurisu K, Ohtani M. Delayed hyperemia causing intracranial hypertension after cardiopulmonary resuscitation.  Crit Care Med. 1997;  25 971-976
    CrossrefPubMedGoogle Scholar
  • 50 Schuier F J, Hossmann K A. Experimental brain infarcts in cats: II. Ischemic brain edema.  Stroke. 1980;  11 593-601
    PubMedGoogle Scholar
  • 51 Bell B A, Symon L, Branston N M. CBF and time thresholds for the formation of ischemic cerebral edema, and effect of reperfusion in baboons.  J Neurosurg. 1985;  62 31-41
    CrossrefPubMedGoogle Scholar
  • 52 Iannotti F, Hoff J T, Schielke G P. Brain tissue pressure in focal cerebral ischemia.  J Neurosurg. 1985;  62 83-89
    PubMedGoogle Scholar
  • 53 Hatashita S, Hoff J T. Cortical tissue pressure gradients in early ischemic brain edema.  J Cereb Blood Flow Metab. 1986;  6 1-7
    PubMedGoogle Scholar
  • 54 Han B K, Towbin R B, De Courten-Myers G, McLaurin R L, Ball Jr W S. Reversal sign on CT: effect of anoxic/ischemic cerebral injury in children.  AJNR Am J Neuroradiol. 1989;  10 1191-1198
    PubMedGoogle Scholar
  • 55 Torbey M T, Paydarfar D, Bigelow C, Recht L. Loss of gray-white matter differentiation (GWMD) predicts poor patient outcome after cardiac arrest.  Neurology. 1999;  52(suppl 2) A61
    PubMedGoogle Scholar
  • 56 Torbey M T, Selim M, Knorr J, Bigelow C, Recht L. Quantitative analysis of the loss of distinction between gray and white matter in comatose patients after cardiac arrest.  Stroke. 2000;  31 2163-2167
    CrossrefPubMedGoogle Scholar
  • 57 Nunes B, Pais J, Garcia R, Magalhaes Z, Granja C, Silva M C. Cardiac arrest: long-term cognitive and imaging analysis.  Resuscitation. 2003;  57 287-297
    CrossrefPubMedGoogle Scholar
  • 58 Arbelaez A, Castillo M, Mukherji S K. Diffusion-weighted MR imaging of global cerebral anoxia.  AJNR Am J Neuroradiol. 1999;  20 999-1007
    PubMedGoogle Scholar
  • 59 Chalela J A, Wolf R L, Maldjian J A, Kasner S E. MRI identification of early white matter injury in anoxic-ischemic encephalopathy [see comment].  Neurology. 2001;  56 481-485
    CrossrefPubMedGoogle Scholar
  • 60 Wijdicks E F, Campeau N G, Miller G M. MR imaging in comatose survivors of cardiac resuscitation [see comment].  AJNR Am J Neuroradiol. 2001;  22 1561-1565
    PubMedGoogle Scholar
  • 61 Els T, Kassubek J, Kubalek R, Klisch J. Diffusion-weighted MRI during early global cerebral hypoxia: a predictor for clinical outcome?.  Acta Neurol Scand. 2004;  110 361-367
    CrossrefPubMedGoogle Scholar
  • 62 Rivkin M J, Volpe J J. Hypoxic-ischemic brain injury in the newborn.  Semin Neurol. 1993;  13 30-39
    PubMedGoogle Scholar
  • 63 Hossmann K A, Fischer M, Bockhorst K, Hoehn-Berlage M. NMR imaging of the apparent diffusion coefficient (ADC) for the evaluation of metabolic suppression and recovery after prolonged cerebral ischemia.  J Cereb Blood Flow Metab. 1994;  14 723-731
    CrossrefPubMedGoogle Scholar
  • 64 Knight R A, Dereski M O, Helpern J A, Ordidge R J, Chopp M. Magnetic resonance imaging assessment of evolving focal cerebral ischemia: comparison with histopathology in rats.  Stroke. 1994;  25 1252-1261 , discussion 1261-1262
    PubMedGoogle Scholar
  • 65 Hossmann K A, Hoehn-Berlage M. Diffusion and perfusion MR imaging of cerebral ischemia.  Cerebrovasc Brain Metab Rev. 1995;  7 187-217
    PubMedGoogle Scholar
  • 66 Sontheimer H, Kettenmann H, Backus K H, Schachner M. Glutamate opens Na + /K + channels in cultured astrocytes.  Glia. 1988;  1 328-336
    CrossrefPubMedGoogle Scholar
  • 67 Kuhn M J, Mikulis D J, Ayoub D M, Kosofsky B E, Davis K R, Taveras J M. Wallerian degeneration after cerebral infarction: evaluation with sequential MR imaging.  Radiology. 1989;  172 179-182
    PubMedGoogle Scholar
  • 68 Pantoni L, Garcia J H, Gutierrez J A. Cerebral white matter is highly vulnerable to ischemia.  Stroke. 1996;  27 1641-1646 , discussion 1647
    PubMedGoogle Scholar
  • 69 Hald J K, Brunberg J A, Dublin A B, Wootton-Gorges S L. Delayed diffusion-weighted MR abnormality in a patient with an extensive acute cerebral hypoxic injury.  Acta Radiol. 2003;  44 343-346
    CrossrefPubMedGoogle Scholar
  • 70 Zingler V C, Krumm B, Bertsch T, Fassbender K, Pohlmann-Eden B. Early prediction of neurological outcome after cardiopulmonary resuscitation: a multimodal approach combining neurobiochemical and electrophysiological investigations may provide high prognostic certainty in patients after cardiac arrest.  Eur Neurol. 2003;  49 79-84
    CrossrefPubMedGoogle Scholar
  • 71 Bassetti C, Bomio F, Mathis J, Hess C W. Early prognosis in coma after cardiac arrest: a prospective clinical, electrophysiological, and biochemical study of 60 patients.  J Neurol Neurosurg Psychiatry. 1996;  61 610-615
    PubMedGoogle Scholar
  • 72 Pfeifer R, Borner A, Krack A, Sigusch H H, Surber R, Figulla H R. Outcome after cardiac arrest: predictive values and limitations of the neuroproteins neuron-specific enolase and protein S-100 and the Glasgow Coma Scale.  Resuscitation. 2005;  65 49-55
    CrossrefPubMedGoogle Scholar
  • 73 Torbey M T, Geocadin R, Bhardwaj A. Brain arrest neurological outcome scale (BrANOS): predicting mortality and severe disability following cardiac arrest.  Resuscitation. 2004;  63 55-63
    CrossrefPubMedGoogle Scholar
  • 74 Kjos B O, Brant-Zawadzki M, Young R G. Early CT findings of global central nervous system hypoperfusion.  AJR Am J Roentgenol. 1983;  141 1227-1232
    PubMedGoogle Scholar
  • 75 Fujioka M, Okuchi K, Miyamoto S et al.. Changes in the basal ganglia and thalamus following reperfusion after complete cerebral ischaemia.  Neuroradiology. 1994;  36 605-607
    CrossrefPubMedGoogle Scholar

Michel T TorbeyM.D. M.P.H. F.A.H.A. 

Director, Neurointensive Care Unit, Medical College of Wisconsin

9200 W. Wisconsin Avenue, Milwaukee, WI 53226

      >